UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057795
Receipt number R000065994
Scientific Title Single-blind randomized controlled trial of the effect of preoperative expiratory muscle training on postoperative swallowing function in patients with esophageal cancer: A phase II trial
Date of disclosure of the study information 2025/06/30
Last modified on 2025/05/02 05:22:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Single-blind randomized controlled trial of the effect of preoperative expiratory muscle training on swallowing function in patients with esophageal cancer: A phase II trial

Acronym

Preoperative expiratory muscle training and swallowing function in esophageal cancer patients

Scientific Title

Single-blind randomized controlled trial of the effect of preoperative expiratory muscle training on postoperative swallowing function in patients with esophageal cancer: A phase II trial

Scientific Title:Acronym

Preoperative expiratory muscle training and postoperative swallowing function in esophageal cancer patients

Region

Japan


Condition

Condition

Patients with thoracic esophageal cancer

Classification by specialty

Gastrointestinal surgery Rehabilitation medicine Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This phase II single-blind randomized controlled trial aims to evaluate the efficacy of expiratory muscle training during neoadjuvant therapy on postoperative swallowing function in patients with thoracic esophageal cancer undergoing esophagectomy.

Basic objectives2

Others

Basic objectives -Others

Postoperative incidence of aspiration will be compared between the two groups to determine the effect size, which will inform the design of a future multicenter collaborative trial.

Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase II


Assessment

Primary outcomes

Penetration-Aspiration Scale (PAS) score assessed during video-fluoroscopic swallowing study

Key secondary outcomes

Repeated Saliva Swallowing Test, Functional Oral Intake Scale, Tongue pressure


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Device,equipment

Interventions/Control_1

Sham-Expiratory muscle training

Interventions/Control_2

Expiratory muscle training

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Eligible participants must meet all of the following criteria and provide written informed consent:

Patients aged 40 years or older with esophageal cancer scheduled to undergo esophagectomy and reconstruction following neoadjuvant therapy at Kindai University Hospital.

Patients receiving initial treatment for esophageal cancer.

Patients without severe comorbidities involving major organs (e.g., bone marrow, heart, liver, kidneys).

Patients who have received a full explanation of the study and have provided written informed consent.

Patients who are able to walk independently.

Key exclusion criteria

Participants meeting any of the following criteria will be excluded from the study:

Patients scheduled to undergo staged esophageal reconstruction or total laryngectomy.

Patients with contraindications to the use of the expiratory muscle training device (EX-1 Medic), including:

Patients with asthma who frequently experience exacerbations

Patients with tympanic membrane perforation or other ear injuries

Patients with markedly elevated left ventricular end-diastolic volume or pressure

Patients who have experienced worsening signs or symptoms of heart failure following respiratory muscle training, or those diagnosed by a physician as being at high risk of such deterioration

Patients with a history of costochondritis or those diagnosed as likely to have it

Patients with active infections or other severe complications* who are judged by the attending physician to be at risk of adverse events associated with expiratory muscle training (EMT), such as increased dyspnea due to respiratory muscle fatigue, decreased consciousness due to hyperventilation, or syncope due to abrupt changes in blood pressure or hemodynamics caused by intrathoracic pressure fluctuations.

Patients with disorientation or psychiatric disorders that would preclude appropriate participation in the study.

Patients deemed by the investigator or sub-investigator to be unsuitable for EMT due to a high risk of pneumothorax from extensive emphysematous lesions or giant bullae, leading to increased physical burden or potential harm from participation in the study.

*Severe complications include severe pneumonia, cardiac disease, hepatic disease, renal disease; patients with cardiac events (e.g., unstable angina, myocardial infarction, percutaneous coronary intervention, coronary artery bypass surgery) within the past month; cerebrovascular disease within the past 6 months; or the presence of extensive emphysematous changes or giant bullae.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Yuji
Middle name
Last name Higashimoto

Organization

Faculty of Medicine, Kindai university

Division name

Department of Rehabilitation Medicine

Zip code

589-5811

Address

377-2, Ohno-Higashi Osakasayama-City, JAPAN

TEL

072-366-0221

Email

yhigashi@med.kindai.ac.jp


Public contact

Name of contact person

1st name Hiroki
Middle name
Last name Mizusawa

Organization

Kindai university hospital

Division name

Department of rehabilitation medicine

Zip code

589-5811

Address

377-2, Ohno-Higashi Osakasayama-City, JAPAN

TEL

072-366-0221

Homepage URL


Email

hiroki-mizusawa@med.kindai.ac.jp


Sponsor or person

Institute

Kindai university hospital

Institute

Department

Personal name



Funding Source

Organization

Grant-In-Aid for Scientific Research from the Ministry of Education, Science and Culture of the Japanese Government

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

he Committee for Ethics of the Kindai University School of Medicine

Address

377-2, Ohno-Higashi Osakasayama-City, JAPAN

Tel

072-366-0221

Email

zizen@med.kindai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 06 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 04 Month 01 Day

Date of IRB

2025 Year 04 Month 09 Day

Anticipated trial start date

2025 Year 05 Month 25 Day

Last follow-up date

2029 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 05 Month 08 Day

Last modified on

2025 Year 05 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065994